Weekly Pediatric News Roundup: Key Developments

In a worrying trend, new data reveals significant declines in Measles-Mumps-Rubella (MMR) vaccination rates across the United States. As the nation grapples with a resurgence of COVID-19, experts are sounding the alarm over the potential risks of vaccine-preventable diseases.

MMR Vaccination Rates Plummet Post-COVID

A recent study published in JAMA sheds light on the alarming statistics: 78% of 2,066 counties assessed saw MMR vaccination rates fall dramatically from 93.9% to 91.3% from 2017 to 2024. While specific states like California, Connecticut, Maine, and New York have seen slight increases, the overall decline poses a growing threat to public health.

These worrying figures correlate with the rising incidence of measles; as of mid-May 2025, the U.S. recorded 1,001 measles cases across 31 jurisdictions—the highest count in over 30 years, excluding 2019's outbreak.

FDA Moves Forward with New Pediatric Treatments

In positive news for pediatric care, the FDA has accepted new applications for two groundbreaking treatments. On June 2, 2025, Ascendis Pharma’s navepegritide (TransCon CNP), aimed at treating achondroplasia in children, received priority review status from the FDA, with a target decision date set for November 30, 2025. This innovative therapy is designed to counter systemic complications associated with this genetic condition.

Meanwhile, on June 4, the SONU Band became the first AI-enhanced, drug-free device approved for treating moderate-to-severe nasal congestion in children aged 12 and older, marking a significant milestone in medical technology for young patients.

Changes to COVID-19 Vaccination Guidelines

In a controversial policy shift, the CDC has adjusted its guidelines for administering the COVID-19 vaccine to healthy children. As of May 27, 2025, COVID-19 vaccines were removed from the routine immunization schedule. However, the CDC has clarified that vaccines can still be administered through shared clinical decision-making between healthcare providers and families. This decision has sparked concerns among pediatric experts about the potential negative impact on vaccination uptake.

Spotlight Case: Mysterious Skin Lesion in Infant

In clinical observations, a 12-month-old girl presented with a unique, pearl-like nodule on her heel—an asymptomatic concern that resolved with monitoring over three months. Such cases underscore the ongoing importance of vigilance and expert consultation in pediatric health.

Stay tuned for more updates on these significant developments in pediatric health, as the landscape continues to evolve amid public health challenges.